Loading...

Kineta, Inc.

KA•NASDAQ
Healthcare
Biotechnology
$0.57
$-0.26(-30.77%)

Kineta, Inc. (KA) Stock Overview

Explore Kineta, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.1/100

Key Financials

Market Cap7M
P/E Ratio-0.96
EPS (TTM)$-1.64
ROE0.72%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.20

KA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kineta, Inc. (KA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.96 and a market capitalization of 7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;